Where and how Kazakhstan's homegrown QazCovid-in vaccine is developed
The Research Institute for Biological Safety Problems held a press tour for reps of Kazakhstani mass media. The institute is a restricted access facility. During the press tour, journalists were able to see how researchers develop Kazakhstan’s homegrown QazCovid-in vaccine. There are 13 laboratories at the institute where all trials, including the preclinical ones, are carried out.